Cytek Biosciences, Inc. (CTKB) Stock

NASDAQ: CTKBLife sciences company providing advanced flow cytometry solutions for scientific research and clinical diagnostics.

Cytek Biosciences stock price chart

CTKB stock quote & key statistics

Cytek Biosciences earnings per share

Income →
Earnings per share

Cytek Biosciences revenue & net income

Income →
RevenueNet income

Cytek Biosciences annual financials

Income statement →
Cytek Biosciences, Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$201.5M-$66.5M-$0.12
FY2024$200.5M-$6.0M$0.16
FY2023$193.0M-$12.1M-$0.05
FY2022$164.0M$2.6M$0.11
FY2021$128.0M$3.0M$0.11

Fiscal year ending December 31. Source: company filings via EODHD.

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc. is a pioneering company in the field of cell analysis solutions, dedicated to advancing biomedical research and clinical applications. The company specializes in providing innovative tools and systems that enable comprehensive cell analysis. Among its flagship products are the aurora and northern lights systems, advanced spectrum flow cytometers that utilize multiple lasers to distinguish fluorescent tags on individual cells. These systems deliver precise cell analysis, empowering researchers to uncover critical insights in various biological processes.

In addition to its cutting-edge cytometry platforms, Cytek Biosciences offers the aurora cell sorter system, which employs full spectrum profiling technology. This capability significantly expands the potential applications of cell analysis, enhancing the depth and breadth of scientific discovery and clinical diagnostics. The company also provides a range of essential reagents and kits, including cFluor reagents fluorochrome-conjugated antibodies essential for identifying specific cells for analysis on their instruments.

Cytek Biosciences further supports researchers with comprehensive solutions such as the 25-color immunoprofiling assay. This assay offers turnkey solutions for identifying major human immune subpopulations, including TBNK cells, monocytes, dendritic cells, and basophils. The company's commitment to innovation extends to its automated micro-sampling and sample loading systems, designed to seamlessly integrate with their cytometry platforms, optimizing workflow efficiency.

Founded in 1992 and headquartered in Fremont, California, Cytek Biosciences serves a diverse customer base including pharmaceutical and biopharmaceutical companies, academic research centers, and clinical research organizations worldwide. With a global presence spanning North America, Europe, China, and the Asia-Pacific region, the company distributes its products through a combination of direct sales channels and strategic partnerships, ensuring broad accessibility and comprehensive customer support.

Cytek Biosciences stock FAQ

What is the Cytek Biosciences stock ticker symbol?

Cytek Biosciences, Inc. trades on the NASDAQ under the ticker symbol CTKB.

What sector and industry is Cytek Biosciences in?

Cytek Biosciences, Inc. is classified in the Healthcare sector, Medical Devices industry.

How many employees does Cytek Biosciences have?

Cytek Biosciences, Inc. has about 682 full-time employees.

What were Cytek Biosciences's revenue and earnings last fiscal year?

Cytek Biosciences reported revenue of $201.5M and net income of -$66.5M in fiscal 2025, with earnings per share of -$0.12. Revenue grew 0.5% from the prior year.

Is Cytek Biosciences in the Russell 2000?

Yes. Cytek Biosciences, Inc. (CTKB) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Cytek Biosciences go public?

Cytek Biosciences stock began trading on July 23, 2021.

Russell 2000 Medical Devices stocks

All Russell 2000 →